VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.
RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD. Cancer Med. 2020 02; 9(3):849-858.
View in:
PubMed
subject areas
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols
Arabinonucleosides
Cyclophosphamide
Dexamethasone
Disease-Free Survival
DNA Mutational Analysis
Doxorubicin
Electronic Health Records
Female
GTP Phosphohydrolases
Humans
Kaplan-Meier Estimate
Male
Membrane Proteins
Middle Aged
Mutation
Neoplasm Recurrence, Local
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Prognosis
Proto-Oncogene Proteins p21(ras)
Risk Assessment
Tumor Suppressor Protein p53
Vincristine
authors with profiles
RAJYALAKSHMI LUTHRA
MARK J ROUTBORT
ZHUANG ZUO
KEYUR PRAVINCHANDRA PATEL
CHI YOUNG OK
SANAM LOGHAVI
BEENU THAKRAL
L JEFFREY MEDEIROS